Literature DB >> 18021937

An oxidized lipid-peroxisome proliferator-activated receptor gamma-chemokine pathway in the regulation of macrophage-vascular smooth muscle cell adhesion.

Jana Barlic1, Philip M Murphy.   

Abstract

Recent genetic studies have implicated pro-inflammatory chemokines and chemokine receptors in atherogenesis. Studies at the molecular and cellular levels have suggested specific atherogenic mechanisms for two chemokine-chemokine receptor pairs, CCL2-CCR2 and CX3CL1-CX3CR1, involving differential receptor regulation by the transcription factor peroxisome proliferator-activated receptor gamma. This pathway is triggered by oxidized proatherogenic lipids, such as oxidized low-density lipoprotein and linoleic acid derivatives, which promote differentiation of CCR2(hi)CX3CR1(lo) human monocytes to CCR2(lo)CX3CR1(hi) macrophages that adhere to coronary artery smooth muscle cells in a CX3CR1- and peroxisome proliferator-activated receptor gamma-dependent manner. Switching CX3CR1 on and CCR2 off in vivo may result in cessation of CCR2-dependent migration and activation of CX3CR1-dependent retention that together may promote foam cell accumulation in the vessel wall.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18021937      PMCID: PMC2149843          DOI: 10.1016/j.tcm.2007.09.004

Source DB:  PubMed          Journal:  Trends Cardiovasc Med        ISSN: 1050-1738            Impact factor:   6.677


  69 in total

Review 1.  Chemokines: key regulators of mononuclear cell recruitment in atherosclerotic vascular disease.

Authors:  Christian Weber; Andreas Schober; Alma Zernecke
Journal:  Arterioscler Thromb Vasc Biol       Date:  2004-08-19       Impact factor: 8.311

2.  The occurrence of peroxidized lipids in atheromatous human aortas.

Authors:  J GLAVIND; S HARTMANN
Journal:  Experientia       Date:  1951-12

Review 3.  Atherosclerosis--an inflammatory disease.

Authors:  R Ross
Journal:  N Engl J Med       Date:  1999-01-14       Impact factor: 91.245

4.  Monocyte chemoattractant protein-1 accelerates atherosclerosis in apolipoprotein E-deficient mice.

Authors:  R J Aiello; P A Bourassa; S Lindsey; W Weng; E Natoli; B J Rollins; P M Milos
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-06       Impact factor: 8.311

5.  Cardiomyocyte-specific knockout and agonist of peroxisome proliferator-activated receptor-gamma both induce cardiac hypertrophy in mice.

Authors:  Sheng Zhong Duan; Christine Y Ivashchenko; Mark W Russell; David S Milstone; Richard M Mortensen
Journal:  Circ Res       Date:  2005-07-28       Impact factor: 17.367

6.  Major reduction of atherosclerosis in fractalkine (CX3CL1)-deficient mice is at the brachiocephalic artery, not the aortic root.

Authors:  Daniel Teupser; Stephanos Pavlides; Marietta Tan; Jose-Carlos Gutierrez-Ramos; Roland Kolbeck; Jan L Breslow
Journal:  Proc Natl Acad Sci U S A       Date:  2004-12-13       Impact factor: 11.205

Review 7.  Peroxisome proliferator-activated receptor-gamma calls for activation in moderation: lessons from genetics and pharmacology.

Authors:  Chris Knouff; Johan Auwerx
Journal:  Endocr Rev       Date:  2004-12       Impact factor: 19.871

8.  MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B.

Authors:  J Gosling; S Slaymaker; L Gu; S Tseng; C H Zlot; S G Young; B J Rollins; I F Charo
Journal:  J Clin Invest       Date:  1999-03       Impact factor: 14.808

9.  Conditional knockout of macrophage PPARgamma increases atherosclerosis in C57BL/6 and low-density lipoprotein receptor-deficient mice.

Authors:  Vladimir R Babaev; Patricia G Yancey; Sergey V Ryzhov; Valentina Kon; Matthew D Breyer; Mark A Magnuson; Sergio Fazio; MacRae F Linton
Journal:  Arterioscler Thromb Vasc Biol       Date:  2005-06-09       Impact factor: 8.311

10.  A Pro12Ala substitution in PPARgamma2 associated with decreased receptor activity, lower body mass index and improved insulin sensitivity.

Authors:  S S Deeb; L Fajas; M Nemoto; J Pihlajamäki; L Mykkänen; J Kuusisto; M Laakso; W Fujimoto; J Auwerx
Journal:  Nat Genet       Date:  1998-11       Impact factor: 38.330

View more
  13 in total

1.  Oxidized metabolites of linoleic acid as biomarkers of liver injury in nonalcoholic steatohepatitis.

Authors:  Nicola Santoro; Sonia Caprio; Ariel E Feldstein
Journal:  Clin Lipidol       Date:  2013-08-01

2.  Hydroxyoctadecadienoic acids: novel regulators of macrophage differentiation and atherogenesis.

Authors:  Venkat Vangaveti; Bernhard T Baune; R Lee Kennedy
Journal:  Ther Adv Endocrinol Metab       Date:  2010-04       Impact factor: 3.565

Review 3.  Homocysteine, Paraoxonase-1 and Vascular Endothelial Dysfunction: Omnibus viis Romam Pervenitur.

Authors:  Esin Eren; Hamit Yasar Ellidag; Ozgur Aydin; Necat Yılmaz
Journal:  J Clin Diagn Res       Date:  2014-09-20

Review 4.  Pulmonary vascular dysfunction in metabolic syndrome.

Authors:  Conor Willson; Makiko Watanabe; Atsumi Tsuji-Hosokawa; Ayako Makino
Journal:  J Physiol       Date:  2018-09-12       Impact factor: 5.182

5.  Diabetic conditions promote binding of monocytes to vascular smooth muscle cells and their subsequent differentiation.

Authors:  Li Meng; Jehyun Park; Qiangjun Cai; Linda Lanting; Marpadga A Reddy; Rama Natarajan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-11       Impact factor: 4.733

Review 6.  Regulation of atherogenesis by chemokines and chemokine receptors.

Authors:  Wuzhou Wan; Philip M Murphy
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2012-12-07       Impact factor: 4.291

Review 7.  Impact of circulating esterified eicosanoids and other oxylipins on endothelial function.

Authors:  Gregory C Shearer; John W Newman
Journal:  Curr Atheroscler Rep       Date:  2009-11       Impact factor: 5.113

8.  Lowering dietary linoleic acid reduces bioactive oxidized linoleic acid metabolites in humans.

Authors:  Christopher E Ramsden; Amit Ringel; Ariel E Feldstein; Ameer Y Taha; Beth A MacIntosh; Joseph R Hibbeln; Sharon F Majchrzak-Hong; Keturah R Faurot; Stanley I Rapoport; Yewon Cheon; Yoon-Mi Chung; Michael Berk; J Douglas Mann
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2012-09-05       Impact factor: 4.006

9.  Hydrogen sulfide inhibits the development of atherosclerosis with suppressing CX3CR1 and CX3CL1 expression.

Authors:  Huili Zhang; Changfa Guo; Duojiao Wu; Alian Zhang; Ting Gu; Liansheng Wang; Changqian Wang
Journal:  PLoS One       Date:  2012-07-18       Impact factor: 3.240

Review 10.  The downstream regulation of chemokine receptor signalling: implications for atherosclerosis.

Authors:  Jyoti Patel; Keith M Channon; Eileen McNeill
Journal:  Mediators Inflamm       Date:  2013-04-14       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.